Alerts will be sent to your verified email
Verify EmailROSEMER
|
Rose Merc
|
Taparia Tools
|
Biogen Pharmachem
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.56 % | 28.37 % | 0.85 % |
|
5yr average Equity Multiplier
|
1.47 | 1.27 | 1.01 |
|
5yr Average Asset Turnover Ratio
|
0.45 | 2.1 | 0.02 |
|
5yr Avg Net Profit Margin
|
-1.9 % | 10.74 % | -19.83 % |
|
Price to Book
|
0.53 | 0.1 | 0.41 |
|
P/E
|
9.35 | 0.29 | 16.28 |
|
5yr Avg Cash Conversion Cycle
|
45.47 Days | 39.86 Days | 0.0 |
|
Inventory Days
|
253.79 Days | 69.02 Days | 0.0 |
|
Days Receivable
|
30.61 Days | 30.39 Days | 0.0 |
|
Days Payable
|
-13.87 Days | 37.7 Days | 3.0 Days |
|
5yr Average Interest Coverage Ratio
|
71.94 | 529.72 | 902.8 |
|
5yr Avg ROCE
|
6.52 % | 37.57 % | 0.2 % |
|
5yr Avg Operating Profit Margin
|
-1.89 % | 13.95 % | -19.88 % |
|
5 yr average Debt to Equity
|
0.03 | 0.0 | 0.0 |
|
5yr CAGR Net Profit
|
28.47 % | 20.44 % | -28.94 % |
|
5yr Average Return on Assets
|
-0.6 % | 22.45 % | 0.19 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.12 % | 71.53 % | 0.0 |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.22 % | 1.81 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Rose Merc
|
Taparia Tools
|
Biogen Pharmachem
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|